Rothwell Investment Advisors, LLC’s Aurinia Pharmaceuticals AUPH Stock Holding History

Rothwell Investment Advisors, LLC’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.1K	Buy	+500	New	+$7.98K	﹤0.01%	810

Other funds holding AUPH

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Ritholtz Wealth Management New York $6.96B AUM 24% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

Hussman Strategic Advisors Ellicott City, Maryland $469M AUM 10.16% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Rothwell Investment Advisors, LLC's AUPH Position: Q3 2026 in Review

Rothwell Investment Advisors, LLC opened a new position in Aurinia Pharmaceuticals (AUPH) in Q3 2026: 500 shares worth $8.1K. The stake represents ﹤0.01% of the portfolio and ranks #810 among its holdings.

102 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.

Rothwell Investment Advisors, LLC held 500 shares of Aurinia Pharmaceuticals worth $8.1K as of Q3 2026.
Aurinia Pharmaceuticals was a new Rothwell Investment Advisors, LLC position in Q3 2026.
Aurinia Pharmaceuticals made up ﹤0.01% of Rothwell Investment Advisors, LLC's portfolio in Q3 2026, its #810 holding.
102 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.

Based on Rothwell Investment Advisors, LLC's 13F filing for Q3 2026, filed 6 Nov 2026.